Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06429748 · ClinicalTrials.gov registry record · NA
Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation
A NA study of Neurologic Symptoms, sponsored by Neuronetics.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06429748: Active NA study of Neurologic Symptoms, sponsored by Neuronetics.
NCT06429748 is a NA study of Neurologic Symptoms that is active but no longer recruiting, run by Neuronetics. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06429748, a NA study of Neurologic Symptoms, is active but no longer recruiting, sponsored by Neuronetics.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective study to evaluate symptoms following repetitive transcranial Magnetic stimulation.
Primary Outcome
Assess changes in multiple symptoms scores based on patient reported questionnaires from baseline to end of acute.
Conditions Studied
Interventions
- DEVICE rTMS
Study Locations (1)
North Carolina
- Charlotte Skin and Laser - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-05-15 |
| Est. Completion | 2027-12-30 |
| Phase | NA |
What the registry record for NCT06429748 still lists
NCT06429748 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Neurologic Symptoms appearing as the primary indexed condition, and to 1 intervention - of which rTMS is the first listed.
NCT06429748 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06429748 about?
NCT06429748 is a clinical study titled "Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation". A prospective study to evaluate symptoms following repetitive transcranial Magnetic stimulation.
What is the current status of trial NCT06429748?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-05-15. Estimated completion is 2027-12-30.
What conditions does trial NCT06429748 study?
This clinical trial studies the following conditions: Neurologic Symptoms.
What interventions are being tested in trial NCT06429748?
The interventions under investigation include: rTMS (DEVICE).
Who is sponsoring clinical trial NCT06429748?
This trial is sponsored by Neuronetics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06429748 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06429748's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI